Harvard Bioscience, Inc. (HBIO)
USD 0.4
(2.44%)
USD 0.4
(2.44%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 24.71 Million USD | -6.52% |
| 2022 | 26.43 Million USD | -4.16% |
| 2021 | 27.58 Million USD | 23.92% |
| 2020 | 22.26 Million USD | 0.91% |
| 2019 | 22.06 Million USD | -12.06% |
| 2018 | 25.08 Million USD | 17.49% |
| 2017 | 21.35 Million USD | 7.01% |
| 2016 | 19.95 Million USD | -10.69% |
| 2015 | 22.34 Million USD | 8.83% |
| 2014 | 20.53 Million USD | 30.13% |
| 2013 | 15.77 Million USD | -11.18% |
| 2012 | 17.76 Million USD | -2.19% |
| 2011 | 18.16 Million USD | 14.7% |
| 2010 | 15.83 Million USD | 9.9% |
| 2009 | 14.4 Million USD | 21.05% |
| 2008 | 11.9 Million USD | -20.57% |
| 2007 | 14.98 Million USD | 39.47% |
| 2006 | 10.74 Million USD | 18.24% |
| 2005 | 9.08 Million USD | -64.32% |
| 2004 | 25.46 Million USD | 3.18% |
| 2003 | 24.67 Million USD | 59.56% |
| 2002 | 15.46 Million USD | 158.97% |
| 2001 | 5.97 Million USD | 60.46% |
| 2000 | 3.72 Million USD | 30.62% |
| 1999 | 2.84 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 24.13 Million USD | -2.35% |
| 2024 Q2 | 25.13 Million USD | 4.12% |
| 2023 Q2 | 26.08 Million USD | -2.87% |
| 2023 Q3 | 25.81 Million USD | -1.04% |
| 2023 Q4 | 24.71 Million USD | -4.27% |
| 2023 Q1 | 26.86 Million USD | 1.6% |
| 2023 FY | 24.71 Million USD | -6.52% |
| 2022 Q4 | 26.43 Million USD | 1.24% |
| 2022 FY | 26.43 Million USD | -4.16% |
| 2022 Q1 | 28.71 Million USD | 4.07% |
| 2022 Q2 | 29.33 Million USD | 2.18% |
| 2022 Q3 | 26.11 Million USD | -10.98% |
| 2021 Q3 | 25.97 Million USD | 5.14% |
| 2021 FY | 27.58 Million USD | 23.92% |
| 2021 Q1 | 22.67 Million USD | 1.86% |
| 2021 Q2 | 24.7 Million USD | 8.97% |
| 2021 Q4 | 27.58 Million USD | 6.19% |
| 2020 Q1 | 23.14 Million USD | 4.9% |
| 2020 Q2 | 23.18 Million USD | 0.16% |
| 2020 Q3 | 22.68 Million USD | -2.12% |
| 2020 Q4 | 22.26 Million USD | -1.88% |
| 2020 FY | 22.26 Million USD | 0.91% |
| 2019 FY | 22.06 Million USD | -12.06% |
| 2019 Q2 | 25.28 Million USD | -4.78% |
| 2019 Q1 | 26.55 Million USD | 5.86% |
| 2019 Q4 | 22.06 Million USD | -7.67% |
| 2019 Q3 | 23.89 Million USD | -5.51% |
| 2018 Q1 | 27.9 Million USD | 30.67% |
| 2018 FY | 25.08 Million USD | 17.49% |
| 2018 Q4 | 25.08 Million USD | -2.53% |
| 2018 Q3 | 25.73 Million USD | 0.37% |
| 2018 Q2 | 25.64 Million USD | -8.09% |
| 2017 FY | 21.35 Million USD | 7.01% |
| 2017 Q3 | 21.38 Million USD | 4.95% |
| 2017 Q2 | 20.37 Million USD | 0.44% |
| 2017 Q1 | 20.28 Million USD | 1.64% |
| 2017 Q4 | 21.35 Million USD | -0.13% |
| 2016 Q1 | 22.21 Million USD | -0.57% |
| 2016 FY | 19.95 Million USD | -10.69% |
| 2016 Q3 | 21.23 Million USD | -4.4% |
| 2016 Q2 | 22.2 Million USD | -0.03% |
| 2016 Q4 | 19.95 Million USD | -6.01% |
| 2015 Q3 | 23.01 Million USD | -0.25% |
| 2015 Q1 | 22.09 Million USD | 7.6% |
| 2015 FY | 22.34 Million USD | 8.83% |
| 2015 Q2 | 23.06 Million USD | 4.42% |
| 2015 Q4 | 22.34 Million USD | -2.9% |
| 2014 Q3 | 18.06 Million USD | 4.95% |
| 2014 Q2 | 17.21 Million USD | 9.12% |
| 2014 Q4 | 20.53 Million USD | 13.66% |
| 2014 Q1 | 15.77 Million USD | -0.03% |
| 2014 FY | 20.53 Million USD | 30.13% |
| 2013 FY | 15.77 Million USD | -11.18% |
| 2013 Q4 | 15.77 Million USD | -12.49% |
| 2013 Q3 | 18.02 Million USD | -1.27% |
| 2013 Q2 | 18.25 Million USD | 3.01% |
| 2013 Q1 | 17.72 Million USD | -0.21% |
| 2012 Q2 | 17.74 Million USD | -3.46% |
| 2012 Q3 | 17.99 Million USD | 1.39% |
| 2012 Q1 | 18.38 Million USD | 1.22% |
| 2012 Q4 | 17.76 Million USD | -1.28% |
| 2012 FY | 17.76 Million USD | -2.19% |
| 2011 FY | 18.16 Million USD | 14.7% |
| 2011 Q4 | 18.16 Million USD | -9.66% |
| 2011 Q3 | 20.1 Million USD | 5.77% |
| 2011 Q2 | 19 Million USD | 6.01% |
| 2011 Q1 | 17.92 Million USD | 13.24% |
| 2010 Q1 | 14.02 Million USD | -2.68% |
| 2010 Q2 | 14.63 Million USD | 4.39% |
| 2010 Q3 | 16.27 Million USD | 11.18% |
| 2010 FY | 15.83 Million USD | 9.9% |
| 2010 Q4 | 15.83 Million USD | -2.7% |
| 2009 Q3 | 15.34 Million USD | 13.28% |
| 2009 Q1 | 11.99 Million USD | 0.81% |
| 2009 FY | 14.4 Million USD | 21.05% |
| 2009 Q4 | 14.4 Million USD | -6.09% |
| 2009 Q2 | 13.54 Million USD | 12.88% |
| 2008 Q3 | 14.71 Million USD | -9.35% |
| 2008 Q1 | 16.2 Million USD | 8.18% |
| 2008 FY | 11.9 Million USD | -20.57% |
| 2008 Q4 | 11.9 Million USD | -19.11% |
| 2008 Q2 | 16.22 Million USD | 0.12% |
| 2007 FY | 14.98 Million USD | 39.47% |
| 2007 Q4 | 14.98 Million USD | 12.66% |
| 2007 Q3 | 13.29 Million USD | 4.49% |
| 2007 Q2 | 12.72 Million USD | 6.42% |
| 2007 Q1 | 11.96 Million USD | 11.33% |
| 2006 Q4 | 10.74 Million USD | -2.4% |
| 2006 FY | 10.74 Million USD | 18.24% |
| 2006 Q3 | 11 Million USD | 4.26% |
| 2006 Q2 | 10.55 Million USD | 10.22% |
| 2006 Q1 | 9.57 Million USD | 5.41% |
| 2005 Q4 | 9.08 Million USD | -6.71% |
| 2005 Q2 | 20.66 Million USD | -19.53% |
| 2005 Q3 | 9.73 Million USD | -52.86% |
| 2005 FY | 9.08 Million USD | -64.32% |
| 2005 Q1 | 25.67 Million USD | 0.82% |
| 2004 FY | 25.46 Million USD | 3.18% |
| 2004 Q4 | 25.46 Million USD | 2.62% |
| 2004 Q3 | 24.81 Million USD | -2.67% |
| 2004 Q1 | 25.7 Million USD | 4.15% |
| 2004 Q2 | 25.49 Million USD | -0.8% |
| 2003 Q3 | 22.84 Million USD | 14.83% |
| 2003 FY | 24.67 Million USD | 59.56% |
| 2003 Q1 | 18.23 Million USD | 17.92% |
| 2003 Q2 | 19.89 Million USD | 9.07% |
| 2003 Q4 | 24.67 Million USD | 8.03% |
| 2002 Q1 | 5.98 Million USD | 0.27% |
| 2002 FY | 15.46 Million USD | 158.97% |
| 2002 Q2 | 6.49 Million USD | 8.5% |
| 2002 Q4 | 15.46 Million USD | 124.46% |
| 2002 Q3 | 6.89 Million USD | 6.05% |
| 2001 FY | 5.97 Million USD | 60.46% |
| 2001 Q2 | 4.71 Million USD | 24.66% |
| 2001 Q3 | 5.26 Million USD | 11.74% |
| 2001 Q1 | 3.78 Million USD | 1.55% |
| 2001 Q4 | 5.97 Million USD | 13.44% |
| 2000 FY | 3.72 Million USD | 30.62% |
| 2000 Q4 | 3.72 Million USD | 0.0% |
| 1999 FY | 2.84 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -38.256% |
| AngioDynamics, Inc. | 60.61 Million USD | 59.225% |
| AtriCure, Inc. | 67.89 Million USD | 63.598% |
| Avinger, Inc. | 5.29 Million USD | -366.516% |
| Azenta, Inc. | 128.19 Million USD | 80.72% |
| BioLife Solutions, Inc. | 43.45 Million USD | 43.124% |
| The Cooper Companies, Inc. | 735.6 Million USD | 96.64% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -389.426% |
| Femasys Inc. | 667.11 Thousand USD | -3604.892% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Hologic, Inc. | 679.8 Million USD | 96.364% |
| ICU Medical, Inc. | 709.36 Million USD | 96.516% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 97.975% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -609.964% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 52.772% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -2784.825% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -2784.825% |
| Masimo Corporation | 545 Million USD | 95.465% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -1428.297% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 91.866% |
| Nephros, Inc. | 2.47 Million USD | -900.648% |
| NovoCure Limited | 38.15 Million USD | 35.217% |
| NEXGEL, Inc. | 1.31 Million USD | -1773.844% |
| NEXGEL, Inc. | 1.31 Million USD | -1773.844% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -82.11% |
| OraSure Technologies, Inc. | 47.61 Million USD | 48.091% |
| Pro-Dex, Inc. | 15.26 Million USD | -61.87% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -4899.454% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -761.755% |
| QuidelOrtho Corporation | 577.8 Million USD | 95.722% |
| Repligen Corporation | 202.32 Million USD | 87.784% |
| Sanara MedTech Inc. | 4.71 Million USD | -423.918% |
| STAAR Surgical Company | 35.13 Million USD | 29.644% |
| Sharps Technology, Inc. | 1.7 Million USD | -1346.112% |
| Utah Medical Products, Inc. | 9.58 Million USD | -157.942% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 96.039% |
| Jin Medical International Ltd. | 5.05 Million USD | -389.122% |